Inactive Instrument

Nanophase Technologies Corporation Stock Other OTC

Equities

NANX

US6300791018

Specialty Chemicals

Sales 2022 37.32M Sales 2023 37.3M Capitalization 29.78M
Net income 2022 -2M Net income 2023 -4M EV / Sales 2022 1.92 x
Net Debt 2022 15.92M Net Debt 2023 14.54M EV / Sales 2023 1.19 x
P/E ratio 2022
-21.2 x
P/E ratio 2023
-6.67 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 33.64%
More Fundamentals * Assessed data
Dynamic Chart
Transcript : Nanophase Technologies Corporation, Q4 2023 Earnings Call, Mar 21, 2024
Nanophase Technologies Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nanophase Technologies Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Nanophase Technologies Corporation announced that it expects to receive $6 million in funding CI
Nanophase Technologies Insider Bought Shares Worth $1,529,946, According to a Recent SEC Filing MT
Transcript : Nanophase Technologies Corporation, Q3 2023 Earnings Call, Nov 14, 2023
Nanophase Technologies Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Nanophase Technologies Corporation, Q2 2023 Earnings Call, Aug 03, 2023
Earnings Flash (NANX) NANOPHASE TECHNOLOGIES CORPORATION Reports Q2 Revenue $11.9M MT
Nanophase Technologies Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Mark E. Miller Joins Nanophase Technologies Corporation's Board of Directors, Effective as of July 19, 2023 CI
Transcript : Nanophase Technologies Corporation, Q1 2023 Earnings Call, May 12, 2023
Nanophase Technologies Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Earnings Flash (NANX) NANOPHASE TECHNOLOGIES CORPORATION Reports Q1 Revenue $9.5M MT
Nanophase Technologies Corporation announced that it expects to receive $1.75 million in funding CI
More news

Latest transcript on Nanophase Technologies Corporation

Managers TitleAgeSince
Chief Executive Officer 59 94-12-31
Chief Tech/Sci/R&D Officer - 94-12-31
Chief Operating Officer 63 12-10-31
Members of the board TitleAgeSince
Chairman 70 03-10-31
Chief Executive Officer 59 94-12-31
Director/Board Member 40 20-10-27
More insiders
Nanophase Technologies Corporation is engaged in minerals-based and scientifically driven healthcare solutions across beauty and life science categories. The Company offers soup-to-nuts production, from engineered materials, formulation development, and finished product development, to commercial manufacturing and packaging capabilities. Its capabilities in materials engineering allow it to coat and disperse materials on a nano and non-nano scale for use in a variety of markets in skin health, including for use in sunscreens as active pharmaceutical ingredients (APIs) and as fully developed skincare products, marketed and sold through its wholly owned subsidiary, Solesence, LLC. The Company manufactures and supplies metric tons of surface-engineered zinc oxide and titanium dioxide to its customers, and these are used by major global consumer products companies for sunscreens and skin health-focused personal care products. It also manufactures and sells advanced nanoparticle materials.
More about the company